03:04
Anaerobic digestion plant overview
02:34
Facility overview - Cramlington, UK - Sterling Pharma Solutions
01:58
Facility overview - Cork, Ireland - Sterling Pharma Solutions
02:30
Facility overview - Wisconsin, US - Sterling Pharma Solutions
02:23
Facility overview - Deeside, UK - Sterling Pharma Solutions
11:17
(Mini webinar) Elevating your approach to high potency APIs
10:42
(Mini webinar) Integrated services for achieving the optimal solid form
41:03
Harnessing analytical chemistry in ADC development
23:08
Overcoming genotoxic impurities through a robust analytical approach
11:40
(Mini webinar) The rise of flow chemistry in API development and manufacturing
36:14
Phase I ADC development and manufacturing: A case study
12:54
API Solid State: The Challenges
02:41
An overview of CDMO, Sterling Pharma Solutions (2022)
31:20
The importance of a seasoned commercial partner: Successfully scaling your product
15:16
The use of mass spectrometry to aid ADC development
02:03
Complex chemistry at Sterling
03:18
ADC services at Sterling
03:16
Late phase API development and manufacturing at Sterling
02:26
Early phase API discovery and development at Sterling
02:55
Analytical chemistry at Sterling
48:13
Positioning your HPAPI programme for success
18:55
Biocatalysis webinar
37:20
Solid form: Why is it important to consider in API development
02:18
Biocatalysis: Using enzymes as catalysts
03:01
Environmental sustainability in the pharmaceutical industry
01:50
High Potency APIs (HPAPIs) are on the rise
02:36
Material Science at Sterling
02:44
Antibody Drug Conjugates (ADCs): The magic bullets
X
About
Sterling is a contract development and manufacturing organisation (CDMO). We provide full-service API development, scale up and cGMP contract manufacturing services from grams to tonnes, combined with Antibody Drug Conjugate (ADC) research and development bioconjugation services.
Tags